Style de citation APA (7e éd.)

F, H., G, A., S, N., B, Z., T, F., & MN, H. (2018). Codelivery of doxorubicin and JIP1 siRNA with novel EphA2-targeted PEGylated cationic nanoliposomes to overcome osteosarcoma multidrug resistance. Dove Medical Press.

Style de citation Chicago (17e éd.)

F, Haghiralsadat, Amoabediny G, Naderinezhad S, Zandieh-Doulabi B, Forouzanfar T, et Helder MN. Codelivery of Doxorubicin and JIP1 SiRNA with Novel EphA2-targeted PEGylated Cationic Nanoliposomes to Overcome Osteosarcoma Multidrug Resistance. Dove Medical Press, 2018.

Style de citation MLA (8e éd.)

F, Haghiralsadat, et al. Codelivery of Doxorubicin and JIP1 SiRNA with Novel EphA2-targeted PEGylated Cationic Nanoliposomes to Overcome Osteosarcoma Multidrug Resistance. Dove Medical Press, 2018.